VYGR · Voyager Therapeutics, Inc.

Summary

Voyager Therapeutics, Inc. filed an 8-K on March 9, 2026, under Item 2.02 with Exhibit 99.1 furnished, indicating results of operations or earnings disclosure. Item 2.02 and Exhibit 99.1 are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.

Key takeaways

• Form 8-K filed on 2026-03-09
• Item 2.02 disclosed
• Exhibit 99.1 furnished relating to Item 2.02
• Item 2.02 not deemed 'filed' under Section 18